Keywords: ciba, market, fomivirsen, approval, vision, licensed, worldwide

Ciba To Market Fomivirsen On Approval

Article | 17 July 1997

- Ciba Vision has licensed worldwide distribution rights to IsisPharmaceuticals' fomivirsen, an antisense drug intended for the treatment of cytomegalovirus retinitis. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Fomivirsen

Vitravene

Go to drug listing